JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on October 17, 2003; DOI: 10.1124/jpet.103.057216


0022-3565/04/3081-156-167$20.00
JPET 308:156-167, 2004
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.103.057216v1
308/1/156    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mello, N. K.
Right arrow Articles by Kelly, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mello, N. K.
Right arrow Articles by Kelly, M.

ENDOCRINE AND REPRODUCTIVE

Ovarian Steroid Hormone Modulation of the Acute Effects of Cocaine on Luteinizing Hormone and Prolactin Levels in Ovariectomized Rhesus Monkeys

Nancy K. Mello, Jack H. Mendelson, S. Stevens Negus, and Maureen Kelly

Alcohol and Drug Abuse Research Center, McLean Hospital-Harvard Medical School, Belmont, Massachusetts

Cocaine stimulates significant increases in luteinizing hormone (LH) and decreases prolactin levels in gonadally intact rhesus monkeys, but cocaine did not alter plasma levels of these anterior pituitary hormones in ovariectomized females. These findings suggested that ovarian steroid hormones may contribute to the endocrine effects of acute cocaine administration. To test this hypothesis, the acute effects of cocaine and placebo-cocaine on plasma LH and prolactin levels were examined in five ovariectomized rhesus females during three chronic hormone replacement conditions: 1) estradiol (E2{beta}) treatment (0.0015-0.006 mg/kg/day i.m.), 2) progesterone treatment (0.32 mg/kg/day i.m.), and 3) combinations of progesterone (0.32 mg/kg/day i.m.) and E2{beta} (0.002 and 0.004 mg/kg/day i.m.). Cocaine (0.8 mg/kg i.v.) did not alter prolactin or LH in ovariectomized monkeys without ovarian steroid replacement. During chronic estradiol treatment, cocaine produced an estradiol dosedependent decrease in prolactin. Cocaine also decreased prolactin during treatment with progesterone alone and progesterone + E2{beta} (0.004 mg/kg/day i.m.). Cocaine stimulated a significant increase in LH during treatment with progesterone alone, but not during treatment with progesterone + E2{beta}, or three of four estradiol treatment doses. Cocaine pharmacokinetics did not differ as a function of hormone replacement conditions. Together, these data suggest that both E2{beta} and progesterone modulate cocaine's effects on prolactin, whereas E2{beta} alone and in combination with progesterone, do not facilitate LH release in response to cocaine in ovariectomized rhesus females.


Received July 17, 2003; accepted September 26, 2003.

Address correspondence to: Dr. Nancy K. Mello, Alcohol and Drug Abuse Research Center, Harvard Medical School-McLean Hospital, 115 Mill St., Belmont, MA 02478. E-mail: mello{at}mclean.org




This article has been cited by other articles:


Home page
Vet PatholHome page
A. K. Remick, C. E. Wood, J. A. Cann, M. K. Gee, E. A. Feiste, N. D. Kock, and J. M. Cline
Histologic and Immunohistochemical Characterization of Spontaneous Pituitary Adenomas in Fourteen Cynomolgus Macaques (Macaca fascicularis).
Vet. Pathol., July 1, 2006; 43(4): 484 - 493.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2004 by the American Society for Pharmacology and Experimental Therapeutics.